Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Where Great Emphasis is Put on Research.

University of Innsbruck: Cancer drug activated by slow electrons

DNA helix © Rebecca Meissner, University of Innsbruck

Researchers at the University of Innsbruck observed that slow electrons from nimorazole molecules are trapped in an extremely effective manner. These results can serve as an explanation for the selective effect of the active ingredient already applied in radiotherapy. At the beginning of the 19th century, the Viennese radiologist Gottwald Schwarz already realized that the oxygen in cells required for their survival also promotes damage done to them as a consequence of radiotherapy. Due to this property, a paradoxical situation arises for fighting cancerous tumours in radiotherapy. This is due to the fact that tumours form areas with a pronounced oxygen shortage as a result of their uninhibited growth. However, due to the lack of oxygen, these regions respond less to the radiation than healthy tissue does.

In order to counteract this effect, different molecules are being tested in the field of cancer medicine which are designed to imitate the effect of oxygen in tumours suffering from a low oxygen level. One molecule which has been successfully tested in clinical studies is the nimorazole molecule. "The experiments with individual molecules show that nimorazole trap slow electrons in an extremely efficient manner. The molecule is also subsequently characterized by a high level of stability by remaining intact", says first author Rebecca Meißner in the study published in the scientific journal Nature Communications.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin



Meet us at events, seminars and trade shows - worldwide.

  • Doing Business in Austria

    03.03.2020, Bratislava, Slovakia

  • Austria as a European window for Russian export opportunities

    05.03.2020, Moscow, Russia

Austria Map

Find the perfect location for your company

Vienna’s unique location at the heart of Europe makes it an important centre and very popular with the global pharmaceutical and biotechnology industry. Vienna is where Eastern Europe meets Western Europe. Businesses located at this international hub benefit from well-established infrastructures and highly-qualified professionals. The significant growth in the Life Sciences sector in Vienna over the last few years is an indicator of the momentum in the industry.

ABF Pharmaceutical Services

ABF Pharmaceutical Services
More testimonials

news from the business location Austria

Many-body quantum physics

Many of the biggest questions in physics can be answered with the help of quantum field theories: They are needed to describe the dynamics of many interacting particles. These theories are just as essential in solid state physics as they are in cosmology.

Growing demand for natural active ingredients enables Phytovalley Tyrol to flourish

The comeback of plant-based active ingredients in medicine, cosmetics and food production has positive impacts on Tyrol as a business location. Austria has succeeded in playing a pioneering role in plant research thanks to the support of the federal government, the Federal Province of Tyrol, the company Bionorica and the University of Innsbruck. This niche in plant research already established itself in Innsbruck years ago.

More news All blog posts